RT Journal Article SR Electronic T1 Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng JF Journal for ImmunoTherapy of Cancer JO J Immunother Cancer FD BMJ Publishing Group Ltd SP e007397 DO 10.1136/jitc-2023-007397 VO 11 IS 6 A1 Aizenbud, Lilach A1 Schoenfeld, David A A1 Caulfield, Jasmine I A1 Mann, Jacqueline E A1 Austin, Matthew R A1 Perdigoto, Ana Luisa A1 Herold, Kevan C A1 Kluger, Harriet M YR 2023 UL http://jitc.bmj.com/content/11/6/e007397.abstract